Pulmatrix, Inc. (PULM)
Last updated: 2026-11-06 11:02:40. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
Summary
Pulmatrix, Inc. (PULM) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $1.48, with a market capitalization of $5.55M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1.06 to $4.98. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$5.55M | |
$1.36 | |
$2,910.00 | |
$1.06 | |
$1.40 | |
-- | |
32.92K | |
-- | |
$4.98 | |
$1.06 | |
-- | |
-- |
Pulmatrix, Inc. (PULM) Pre-Market Stock Price
Pulmatrix, Inc. (PULM) is trading at $1.48 in pre-market trading as of 2026-11-06 09:07:00, up 5.43% ($0.08) from the previous close of $1.40
Pre-market trading shows how investors are pricing PULM before the regular session opens. The current pre-market price is above the previous close, indicating positive early trading sentiment.
Pulmatrix, Inc. (PULM) 7-Day Stock Price Change
Over the past seven days, Pulmatrix, Inc. (PULM) moved from $1.50 to $1.48, representing a decline of 1.60% ($0.02).
The stock traded between $1.06 and $1.54 during the period. The latest price is near the upper end of the 7-day range, indicating moderate downward.
The average daily volume was 59.79 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
PULM 52-Week Price Position
Position in Range: 10.6%
PULM is currently trading at $1.48, placing it 10.6% of the way from its 52-week low of $1.06 to its 52-week high of $4.98. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is Pulmatrix, Inc. (PULM)?
Pulmatrix Inc is a biopharmaceutical company focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs using its patented dry powder delivery technology, iSPERSE. Its pipeline of clinical assets includes PUR3100 for the treatment of acute migraine, PUR1800 for the treatment of acute exacerbations of chronic obstructive pulmonary disease (AECOPD), and PUR1900 for the treatment of ABPA in patients with asthma and in patients with cystic fibrosis (CF).
Pulmatrix, Inc. Information
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 2 |
| Exchange | NASDAQ |
| Company Website |
How to Buy Pulmatrix, Inc. (PULM) Stock on MEXC
Eligible investors can buy real shares of Pulmatrix, Inc. (PULM) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is Pulmatrix, Inc. (PULM) stock price today?
2.Is PULM stock going up or down today?
3.What is PULM pre-market price?
4.What is PULM after-hours price?
5.Is PULM stock trading now?
6.Where does PULM sit relative to its 52-week high and low?
7.What sector is Pulmatrix, Inc. in?
8.What is Pulmatrix, Inc.'s market capitalization and where is it listed?
9.How is PULM valued in terms of P/E ratio and EPS?
10.Does Pulmatrix, Inc. pay a dividend?
Explore More US Stocks
Search Stocks
PULM Stock Calculator
Estimate the value between PULM shares and USD.
PULM Shares to USD
1.00 PULM shares = 1.476 USD
Calculations are estimates based on the latest available price and are for reference only.


